NCT05077800 2026-04-13FOLFIRINOX + Elraglusib + Losartan In Pancreatic CancerMassachusetts General HospitalPhase 2 Active not recruiting70 enrolled
NCT05624918 2026-04-08A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic AdenocarcinomaBig Ten Cancer Research ConsortiumPhase 2 Recruiting38 enrolled